Clinical trial · Observational

New Genes in the Carcinogenesis of Colorectal Cancer

Investigating the Role of SPG20,STK31 Genes in the Carcinogenesis of Colorectal Cancer

NCT03261752CI-TRIAL-00034003unknownClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

Colo rectal cancer is one of the greatest ,mutual malignancies worldwide ,accounting for an estimated 1.3 million new cases and \>500,000 mortality ⁄ year . is the fourth leading cause of cancer-associated mortality worldwide with speedily ,cumulative ,occurrence rate in the worldwide

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Colo-rectal Cancer	Colon Neoplasm	ALIAS	0.90

Interventions

Interventions (1)

Intervention	Type	Mapped drug	Match
blood sample	Diagnostic Test	—	UNRESOLVED

Design

Arms and outcomes

Arms (2)

label
patient with cancer
description
blood sample will be collected from patient before and after treatment (surgery or chemotherapy)
interventionNames
1. Diagnostic Test: blood sample
label
healthy people
description
blood sample will be collected for comparison
interventionNames
1. Diagnostic Test: blood sample

Primary outcomes (1)

measure
detection of SPG20&STK31 genes
timeFrame
5 months
description
detection of SPG20\&STK31 genes and prediction future treatment for colo-rectal cancer

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 35 Years
Maximum age: 65 Years

Show eligibility criteria text

Inclusion Criteria:

* age between 35-65
* patient with colorectal cancer (at any stage)
* both sex included

Exclusion Criteria:

* pediatric patients
* patient with insufficient data
* cardiac patient
* pregnant women

References

Publications (0)

Data not yet available

No reference posted for this study.